City Therapeutics to present Phase 1 CITY-FXI data at ASH 2026
Tweet Send to a Friend
City Therapeutics, Inc. (Nasdaq: CTY) announced that data from two of its drug programs will be presented at the 68th ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




